Clinical Trial Update: Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating immunotherapy versus observation in HPV-positive oropharyngeal cancer is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oropharyngeal Cancer

Drugs mentioned

• Immunotherapy (unspecified)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Phase 3 | Status: ACTIVE_NOT_RECRUITING